ComponentsFor 1 Test/Box For 5 Tests/Box For 20 Tests/Box (3 Rapid SARS-CoV-2 Antigen Test Card (sealed foil pouch) 1 5 20 Sterilized swab3. Do not use the product if the po 1 5 20 Extraction tube 1 9.5 20 Sample extraction buffer 1 5 20 Instructions for use (this leaflet) 1 1 werden darf.1 Ap. The FDA has granted an Emergency Use Authorization (EUA) to Xiamen Boson Biotech for its Rapid SARS-CoV-2 Antigen Test Card for COVID-19. The over-the-counter home test is authorized to detect viral antigens in individuals with symptoms of COVID-19 within the first six days of symptom onset or in asymptomatic individuals with Forserial testing, the BinaxNOW COVID-19 Antigen Self Test should be performed twice over 3 days, at least 24 hours (and no more than 48 hours) apart. For symptomatic use, a single test can be used. The BinaxNOW COVID-19 Ag 2 Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein FiveRAD tests commonly sold in Belgian pharmacies were used : (i) the Clinitest ® Rapid COVID-19 Antigen test (Siemens Healthineers, Buizingen, Belgium), (ii) the New-gene COVID-19 Antigen Detection Kit (New -gene Bioengineering, Hangzhou, China), (iii) the Boson Rapid SARSCoV--2 Antigen Test Card (Xiamen Boson Biotech ForRapid Antibody Test Kits to be procured by the DOH, HTAC recommends a minimum sensitivity and specificity of 98% for specimens collected 20 days or more after the appearance of first symptoms. This standard metric is explained in depth in the Guidance Document on the Technical Requirements for SARS-COV-2 Rapid Rapidantigen tests, such as the Abbott BinaxNOW COVID-19 Ag Card (BinaxNOW), offer results more rapidly (approximately 15–30 minutes) and at a lower cost than do highly sensitive nucleic acid amplification tests (NAATs) (1).Rapid antigen tests have received Food and Drug Administration (FDA) Emergency Use Authorization (EUA) RapidSARS-CoV-2 Antigen Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of SARS-CoV-2 virus antigen in anterior nasal swabs from individuals suspected of COVID19 within the first seven days of symptom onset. Xiamen Boson Biotech AllTest SARS-CoV-2 Antigen Rapid Test (Nasal Swab) Self-Test (INCP-502H) (pdf,649kb) (Rapid antigen test) Nasal swab: AM Diagnostics: Hangzhou Alltest Biotech Co Ltd (China) 376310: Very high sensitivity: 13 October 2021: 24 Months (extended) CareStart COVID-19 Antigen Home Test (pdf,6.17Mb) (Rapid antigen test) Ahighly accurate, rapid, at home self-use test for the detection of SARS-CoV-2 antigens in anterior nasal specimens. Includes 500 total tests (2 Tests/Pack, 250 Packs/Case). XiamenBoson Biotech Co., Ltd. 90-94 Tianfeng Road Jimei North Industrial Park Xiamen, Fujian 361021, China Re: EUA220120/S012 Trade/Device Name: Rapid SARS-CoV-2 Antigen Test Card Dated .

boson biotech rapid sars cov 2 antigen test card